Aarti Industries Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/8ldoltztmndkajqkvs4a66hr.pdf

Key Takeaways


Volume & Demand Recovery

Kotecha: "Frankly, I would be totally honest, it is very difficult for us to forecast gasoline-naphtha spreads, especially in different crude price environments. I think I have seen forecasts from three different agencies in the last six months and none of them have panned out the way they were supposed to be."

Tariff Impact: Mixed & Unfolding

Kotecha: "So I think if you want one line summary, then I can say that the overall US tariff impact in terms of AIL is a bit mixed, right. Because it is complex, we have a wide variety of product portfolio, and different products have different implications because some products are part of Annexure-2, and some products are not part of Annexure 2."

Margin & Pricing Pressure

Kotecha: "So right now our base assumption, we are factoring in most of the growth led by volumes. So, we are not factoring the significant recovery in the margins because we do not see the demand supply imbalances from China getting corrected soon."

Chain-by-Chain Utilization Outlook

ChainOutlookCommentary
PDA▲ Uptick expectedUnderperformer for years; US tariff issues driving demand increase, significant utilization improvement expected.
NCB▲ Ramping upLarge pharma customers increasing capacity; utilization expected to rise from current levels through the year.
Nitrotoluene & Ethylation▲ Higher utilizationLinked chains (NT provides raw material for ethylation); full capacity proven only in Q4 FY25, ramp-up is a process.
DCB▬ Maintain levelsDownstream PPS demand into automotive under pressure; some US/Japan demand impact possible; near-term inflow from US customers advancing shipments for tariff certainty.
MMA▬ Market development underwayVolume up 38%+ over two years; targeting full utilization of current capacity over the next two years, timeline depends on market development success.
Kotecha: "No, I think competition will come, right. I think people do track us closely, and in that context it is expected that competition will come up as and when we scale up certain products. But that's perfectly fine, if more people are trying to develop the market, it also works in the industry's favor."

Capex, Balance Sheet & Cash Flow


Guidance & Commitments

CommitmentSpecificsTimeline
Three-year plan deliveryRemain on track; guidance unchanged despite volatile macrosEnd of three-year plan period
Zone-4 capex completionBulk of Zone-4 capex to be completedWithin FY26
Zone-4 plant startupsMultipurpose plant and calcium chloride plant to start upQ3 FY26
Renewable energy PPA deliveryOne contract to start delivering powerWithin calendar year 2025
Renewable energy PPA deliverySecond contract to begin power deliveryEnd FY26 or early FY27
Cost optimization EBITDA accrualBulk of implementation in FY26; full EBITDA contribution from hybrid projectsStart of FY27
Tariff situation settlementAnticipate tariff issues to settle downNext 2–4 months
Volume growth sourceLarge part from existing commissioned assets; Zone-4 contribution only from FY27FY26

Key Metrics

MetricQ4 FY25
Revenue₹2,214 cr, +9% QoQ
EBITDA₹266 cr, +13% QoQ
PAT₹96 cr, driven by cost efficiencies from higher volumes
FY25 full-year revenue₹8,046 cr, +15% YoY
FY25 full-year EBITDA₹1,016 cr, +3% YoY
FY25 full-year PAT₹331 cr
FY26 capex guidance₹950–1,000 cr, down from ₹1,372 cr in FY25
Volume growth (non-energy)~14% QoQ
Volume growth (energy applications)21% QoQ
Volume growth (FY25 overall portfolio)~17% YoY
Export revenue₹1,240 cr, 55% of Q4 revenue vs 48–50% in prior period
Net debt~₹3,500 cr at year-end, expected to decline by ₹200–300 cr in FY26
Working capital days70–80 days on a gross basis, expected for FY26
Final dividend₹1 per share (20% of face value of ₹5 each) for FY25